With over a decade of experience in the biotechnology sector, Andy brings a strong scientific background and a focus on the evaluation and development of innovative projects.
Throughout his career, he has held operational roles in various companies, covering areas from preclinical regulatory phases to pharmaceutical development (CMC) and clinical trials, with active involvement in both scientific and operational management.
He holds a degree in Biochemistry and a Ph.D. in Molecular Biology, and gained postdoctoral experience before transitioning into the business world.
